EWA
RVMD icon

EverSource Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

EverSource Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
598
+366
+158% +$53.5K ﹤0.01% 1322
2026
Q1 		$22.6K Buy
232
+92
+66% +$9.29K ﹤0.01% 2434
2025
Q4 		$11.2K Buy
140
+8
+6% +$525 ﹤0.01% 2742
2025
Q3 		$6.17K Buy
132
+95
+257% +$3.72K ﹤0.01% 3062
2025
Q2 		$1.36K Sell
37
-71
-66% -$2.73K ﹤0.01% 3639
2025
Q1 		$3.82K Buy
108
+51
+89% +$2.07K ﹤0.01% 2625
2024
Q4 		$2.49K Buy
57
+29
+104% +$1.46K ﹤0.01% 2633
2024
Q3 		$1.27K Buy
28
+23
+460% +$1K ﹤0.01% 2665
2024
Q2 		$229 Buy
+5
New +$187 ﹤0.01% 2970

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

EverSource Wealth Advisors's RVMD Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Revolution Medicines (RVMD) stake by 158% in Q2 2026, buying an estimated $53.5K and bringing the position to 598 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

EverSource Wealth Advisors first reported a position in RVMD in Q2 2024 and has held it in 9 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • EverSource Wealth Advisors held 598 shares of Revolution Medicines worth $112K as of Q2 2026.
  • EverSource Wealth Advisors bought 366 Revolution Medicines shares in Q2 2026, an estimated $53.5K.
  • Revolution Medicines made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1322 holding.
  • EverSource Wealth Advisors first reported a position in Revolution Medicines in Q2 2024 and has held it in 9 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.